Long-term warfarin therapy in thromboembolism prevention among atrial fibrillation patients without heart valve pathology

Long-term warfarin therapy in thromboembolism prevention among atrial fibrillation patients without heart valve pathology

.

Bibliographic Details
Main Authors:	G. V. Arkadyeva, A. E. Radzevich
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2005-12-01
Series:	Российский кардиологический журнал
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/2342

Similar Items

Warfarin and its role in the prevention of thromboembolism in atrial fibrillation (lecture)
by: Y. V. Shubik
Published: (2015-12-01)

THE ENDOVASCULAR PREVENTION OF THROMBOEMBOLISM IN ATRIAL FIBRILLATION
by: Rami N. Al-Ayyubi, et al.
Published: (2018-12-01)

Percentage of time in therapeutic range and proportion of thromboembolic event in nonvalvular atrial fibrillation patient on warfarin
by: Mohd, Fahmi Nazrin
Published: (2015)

Warfarin doses in the initiation phase among patients with heart valve replacement and atrial fibrillation in Hospital Pulau Pinang
by: Jia, Teoh Chee
Published: (2011)

Warfarin doses in the initiation phase among patients with heart valve replacement and atrial fibrillation in Hospital Pulau Pinang
by: Jia, Teoh Chee
Published: (2011)

Long-term discontinuation of warfarin in a patient with HeartMate 3 left ventricular assist device without thromboembolic events
by: Yoganiranjana Dharuman, et al.
Published: (2024-06-01)

Warfarin therapy in patients with coronary heart disease and atrial fibrillation: drug interactions and genetic sensitivity to warfarin
by: O. A. Panibratiuk, et al.
Published: (2020-06-01)

Indirect anticoagulants for prevention and treatment of thrombosis and embolia in cardiovascular pathology
by: G. V. Arkadyeva, et al.
Published: (2007-06-01)

The Anticoagulation in Patients with Atrial Fibrillation: Rivaroxaban and Warfarin
by: I. Yu. Koroleva, et al.
Published: (2016-11-01)

RIVAROXABAN IN THE PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN PATIENTS WITH ATRIAL FIBRILLATION
by: M. Yu. Gilyarov
Published: (2015-12-01)

Prevention of thromboembolic complications in patients with atrial fibrillation and obesity
by: Izabela Kolasa, et al.
Published: (2023-04-01)

RIVAROXABAN IN THE PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN PATIENTS WITH ATRIAL FIBRILLATION
by: M. Yu. Gilyarov
Published: (2015-12-01)

PREDICTION OF THROMBOEMBOLISM IN PATIENTS WITH LONG-LASTING ATRIAL FIBRILLATION
by: R. D. Kurbanov, et al.
Published: (2014-03-01)

NOVEL ANTICOAGULANTS FOR THROMBOEMBOLIC COMPLICATIONS PREVENTION IN NONVALVULAR ATRIAL FIBRILLATION
by: D. A. Itkin, et al.
Published: (2015-02-01)

The role of edoxaban in preventing thromboembolic complications in patients with atrial fibrillation
by: O. O. Shakhmatova
Published: (2020-12-01)

Prevention of thromboembolic events in patients with atrial fibrillation – new anticoagulants
by: Alexandre Holthausen Campos, et al.
Published: (2011-09-01)

Warfarin versus aspirin for prevention of cognitive decline in atrial fibrillation: randomized controlled trial (Birmingham Atrial Fibrillation Treatment of the Aged Study).
by: Mavaddat, N, et al.
Published: (2014)

Atrial fibrillation: Primary prevention, secondary prevention, and prevention of thromboembolic complications: Part 2
by: Richard G. Trohman, et al.
Published: (2023-03-01)

Atrial fibrillation: primary prevention, secondary prevention, and prevention of thromboembolic complications: part 1
by: Richard G. Trohman, et al.
Published: (2023-06-01)

Long-Term Effects of Postoperative Atrial Fibrillation following Mitral Valve Surgery
by: Haneen Alghosoon, et al.
Published: (2023-07-01)

The relative importance of barriers to the prescription of warfarin for nonvalvular atrial fibrillation.
by: Bungard, T, et al.
Published: (2003)

CAN CLOPIDOGREL FULLY SUBSTITUTE WARFARIN AND DABIGATRAN IN ATRIAL FIBRILLATION?
by: A. B. Sumarokov
Published: (2013-08-01)

PHARMACOECONOMIC ASPECTS OF APIXABAN FOR PREVENTION OF THROMBOEMBOLIC EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION
by: A. V. Rudakova
Published: (2015-09-01)

Predictors of Direct Oral Anticoagulants Utilization for Thromboembolism Prevention in Atrial Fibrillation
by: Caroline Brais, et al.
Published: (2017-01-01)

PHARMACOECONOMIC ASPECTS OF APIXABAN FOR PREVENTION OF THROMBOEMBOLIC EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION
by: A. V. Rudakova
Published: (2015-09-01)

Preventing bleeding and thromboembolic complications in atrial fibrillation patients undergoing surgery
by: Charles André
Published: (2015-08-01)

LEFT ATRIAL APPENDAGE CLOSURE AS AN ALTERNATIVE TO WARFARIN FOR STROKE PREVENTION IN ATRIAL FIBRILLATION: A PATIENT¬LEVEL META¬ANALYSIS
Published: (2016-03-01)

PHARMACOECONOMIC EVALUATION OF DABIGATRAN VS WARFARIN IN CARDIOVASCULAR EVENTS PREVENTION IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION
by: Yu. B. Belousov, et al.
Published: (2015-12-01)

PHARMACOECONOMIC EVALUATION OF DABIGATRAN VS WARFARIN IN CARDIOVASCULAR EVENTS PREVENTION IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION
by: Yu. B. Belousov, et al.
Published: (2015-12-01)

Thromboembolic prevention in athletes: management of anticoagulation in sports players affected by atrial fibrillation
by: Simona Minardi, et al.
Published: (2024-05-01)

Safety and efficacy of dabigatran versus warfarin in Asian patients with atrial fibrillation
by: Inche Mat, Liyana Najwa, et al.
Published: (2020)

Physicians' perceptions of the benefits and risks of warfarin for patients with nonvalvular atrial fibrillation.
by: Bungard, T, et al.
Published: (2001)

Is warfarin a safe alternative to aspirin in elderly patients with atrial fibrillation?
by: Mant, J, et al.
Published: (2008)

ANALYSIS OF DIRECT COSTS ASSOCIATED WITH THE USE OF WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION
by: Yu. B. Belousov, et al.
Published: (2016-01-01)

INCREASED ADHERENCE TO WARFARIN TREATMENT WITH TRAINING PROGRAMS IN PATIENTS WITH ATRIAL FIBRILLATION
by: E. D. Djishambaev, et al.
Published: (2020-12-01)

Optimizing warfarin dosing for patients with atrial fibrillation using machine learning
by: Jeremy Petch, et al.
Published: (2024-02-01)

Warfarin therapy in atrial fibrillation: assessment of patient knowledge of risks and benefits
by: P. Fitzgerald, et al.
Published: (2020-05-01)

Long-term clinical outcome of atrial fibrillation ablation in patients with history of mitral valve surgery
by: Alexandre Almorad, et al.
Published: (2022-12-01)

Comparison between non-vitamin K oral antagonist versus warfarin in atrial fibrillation with and without valvular heart disease: a systematic review and meta-analysis
by: Arga Setyo Adji, et al.
Published: (2024-08-01)

Response to letter regarding article, "warfarin versus aspirin for prevention of cognitive decline in atrial fibrillation: randomized controlled trial (birmingham atrial fibrillation treatment of the aged study)".
by: Mavaddat, N, et al.
Published: (2014)